Suppressing the progression of bladder cancer by inhibiting the secretion of IL-10 and TGF-β by MDSCs and Tregs (4 mg/kg twice a week for 35 days, i.p.) The gene discussed is TGFB1; the disease is urinary bladder carcinoma.